Renaissance Technologies (RenTech)'s LTRN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 291,039 shares of Lantern Pharma Inc. (LTRN) worth $1.21 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in LTRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 175,039 shares. Largest reduction occurred in Q3 2023, reducing 6,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Lantern Pharma (LTRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lantern Pharma (LTRN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +175,039 | Add 150.90% | 291,039 | $4.17 |
| Q1 2026 | +5,600 | Add 5.07% | 116,000 | $1.37 |
| Q4 2025 | +10,300 | Add 10.29% | 110,400 | $3.03 |
| Q3 2025 | +9,500 | Add 10.49% | 100,100 | $4.35 |
| Q2 2025 | +1,800 | Add 2.03% | 90,600 | $3.16 |
| Q1 2025 | +1,500 | Add 1.72% | 88,800 | $3.54 |
| Q4 2024 | +3,300 | Add 3.93% | 87,300 | $3.19 |
| Q3 2024 | +2,200 | Add 2.69% | 84,000 | $3.67 |
| Q2 2024 | +16,100 | Add 24.51% | 81,800 | $4.67 |
| Q1 2024 | +21,900 | Add 50.00% | 65,700 | $8.80 |
| Q4 2023 | +5,700 | Add 14.96% | 43,800 | $4.27 |
| Q3 2023 | -6,800 | Reduce 15.14% | 38,100 | $3.41 |
| Q2 2023 | +20,300 | Add 82.52% | 44,900 | $0.01 |
| Q1 2023 | +3,500 | Add 16.59% | 24,600 | $0.00 |
| Q4 2022 | -200 | Reduce 0.94% | 21,100 | $0.01 |
| Q3 2022 | -800 | Reduce 3.62% | 21,300 | $4.79 |
| Q2 2022 | +11,400 | Add 106.54% | 22,100 | $5.70 |
| Q1 2022 | +10,700 | New Buy | 10,700 | $7.20 |
Renaissance Technologies (RenTech)'s Lantern Pharma Investment FAQs
Renaissance Technologies (RenTech) first purchased Lantern Pharma Inc. (LTRN) in Q1 2022, acquiring 10,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Lantern Pharma Inc. (LTRN) for 18 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Lantern Pharma Inc. (LTRN) was in Q2 2026, adding 291,039 shares worth $1.21 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 291,039 shares of Lantern Pharma Inc. (LTRN), valued at approximately $1.21 M.
As of the Q2 2026 filing, Lantern Pharma Inc. (LTRN) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Lantern Pharma Inc. (LTRN) was 291,039 shares, as reported at the end of Q2 2026.